New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
The Silent Struggle: Unmasking the Prevalence of Dysphagia in EDS and HSD on October 2, 2026 Posted by
The Hidden Cost of Shelf Life: New Study Links Common Food Preservatives to Cardiovascular Risk on October 2, 2026 Posted by
Understanding Obsessive-Compulsive Disorder: A Comprehensive Guide to Symptoms, Causes, and Modern Treatment on October 2, 2026 Posted by
The Rhythms of Life: An Ayurvedic Perspective on Menstrual Health and Hormonal Harmony on October 2, 2026 Posted by
New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
The Silent Struggle: Unmasking the Prevalence of Dysphagia in EDS and HSD on October 2, 2026 Posted by
Posted in Respiratory Health Shaping the Future of Rare Disease Care: A Call to Action for the Inaugural ERS Alpha-1 Antitrypsin Conference on May 11, 2026 rifanmuazin
Posted in Nutrition and Recovery The Intersection of Obesity and COVID-19: Unmasking the Syndemic of Chronic and Infectious Disease on May 10, 2026 rifanmuazin
Posted in Cardiovascular Recovery Breakthrough Experimental Drug IC7Fc Shows Promise in Combatting Cardiovascular Disease on May 10, 2026 rifanmuazin
Posted in Cardiovascular Recovery The Great Debate: Should STEMI Patients with Multivessel Disease Undergo Immediate or Staged Revascularization? on May 10, 2026 rifanmuazin
Posted in Digital Health Tools Angelini Pharma’s $4.1 Billion Strategic Leap: A New Chapter in Global Rare Disease Treatment on May 10, 2026 rifanmuazin
Posted in Chronic Pain Management Bridging the Gap: Bionews Launches "The Rare Journey" to Humanize the Rare Disease Experience on May 9, 2026 rifanmuazin
Posted in Geriatric Care A Decade of Advocacy: Marking 10 Years of Heart Valve Disease Awareness on May 9, 2026 rifanmuazin
